DATASHEET
Host:
Rabbit
Target Protein:
OSTM1
Immunogen Range:
21-120/334
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
28962
Swiss Prot:
Q86WC4
Source:
KLH conjugated synthetic peptide derived from human OSTM1
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
OSTM1 (osteopetrosis associated transmembrane protein 1), also known as gl (gray-lethal) or HSPC019, is a 338 amino acid single-pass type I membrane protein that is expressed primarily in osteoclasts and melanocytes as well as brain, kidney and spleen. Bone autosomal recessive osteopetrosis (ARO) is the most severe form of hereditary bone disease whose cellular basis is in the osteoclast and is characterized by abnormally dense bone, due to defective resorption of immature bone. ARO is suggested to be caused by mutations in the OSTM1 gene. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Defects in the OSTM1 gene are also the cause of the spontaneous gl mutant, which is responsible for a coat color defect in mice.
VALIDATION IMAGES
Formalin-fixed and paraffin embedded rat kidney labeled with Rabbit Anti OSTM1 Polyclonal Antibody, Unconjugated (bs-8506R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
L1 human colon carcinoma lysates probed with Anti OSTM1 Polyclonal Antibody, Unconjugated (bs-8506R) at 1:200 overnight at 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 for 90 min at RT. Predicted band 37kD. Observed band size:37kD.\n
Lane 1: Mouse Spleen tissue lysates; Lane 2: Mouse Lung tissue lysates; Lane 3: Rat Liver tissue lysates; Lane 4: Rat Spleen tissue lysates; Lane 5: Human U87MG cell lysates; Lane 6: Human U251 cell lysates; Lane 7: Human THP-1 cell lysates probed with OSTM1 Polyclonal Antibody, Unconjugated (bs-8506R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.